Janssen vaccine

May 12 2022

(READ) FDA limits J&J Covid-19 vaccine due to blood clot risk

By Sharyl Attkisson / May 12, 2022

The following information is from the FDA re: its decision to limit use of J&J Covid-19 vaccine due to blood clot risk. Today, the U.S. Food and Drug Administration has limited the authorized use of the Janssen COVID-19 Vaccine to […]

(READ) FDA limits J&J Covid-19 vaccine due to blood clot risk Read More »

Apr 18 2021

(READ) CDC-FDA statement on Johnson & Johnson Covid-19 vaccine

By Staff / April 18, 2021

Below is the statement released on April 13 by CDC and FDA regarding blood clots associated with the Johnson & Johnson Covid-19 vaccine: Joint CDC and FDA Statement on Johnson & Johnson COVID-19 VaccineThe following statement is attributed to Dr.

(READ) CDC-FDA statement on Johnson & Johnson Covid-19 vaccine Read More »

(READ) FDA limits J&J Covid-19 vaccine due to blood clot risk

(READ) CDC-FDA statement on Johnson & Johnson Covid-19 vaccine

Keep Independent Journalism Alive

Subscribe To The Newspresso Daily